Insiders UroGen Pharma Ltd.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-21 EDT			5-day change	1st Jan Change
16.51 ^USD	+6.72%		-14.01%	+10.07%

06-18	Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Ahead of Speeches by Fed Officials	MT
06-14	Oppenheimer Adjusts UroGen Pharma Price Target to $40 From $32, Maintains Outperform Rating	MT

UroGen Pharma Appoints David Lin as New Chief Commercial Officer	06-03	CI
UroGen Pharma Ltd. Announces the Appointment of James Robinson to Its Board of Directors	23-07-25	CI
Urogen Pharma Ltd. Appoints Dan Wildman to the Board of Directors	22-11-09	CI
Urogen Pharma Ltd. Appoints Dr. Leana S. Wen to the Board of Directors and Audit Committee	22-09-12	CI
Phathom Pharmaceuticals Names Molly Henderson Finance, Business Chief	22-03-22	MT
Insider Sell: Urogen Pharma	22-01-07	MT
Tyme Technologies : Names Frank Porfido CFO	21-05-13	MT
UroGen Pharma Announces Board Appointments	20-09-09	CI
UroGen Pharma Appoints Molly Henderson as Chief Financial Officer, Effective October 1, 2020	20-09-09	CI
Urogen Pharma Ltd. Announces Executive Promotions	20-03-23	CI
UroGen Pharma Ltd. Announces Executive Changes	19-01-03	CI
Jones “Woody” Bryan Joins UroGen Pharma Ltd. as Senior Vice President of Business Development	18-09-11	CI
UroGen Pharma Ltd. Announces Resignation of Gil Hakim, President, Israel Operations	18-08-30	CI
UroGen Pharma Ltd. Appoints Peter P. Pfreundschuh as Chief Financial Officer, Effective August 20, 2018	18-08-08	CI
Urogen Pharma Appoints Shawn Cline Tomasello to its Board of Directors	18-07-10	CI
UroGen Pharma Ltd Announces Executive Changes	18-06-05	CI
UroGen Pharma Ltd. Appoints Stephen Mullennix as Chief Operating Officer	18-02-14	CI
Urogen Pharma Ltd. Announces Executive Appointments	18-01-08	CI
Urogen Pharma Ltd. Announces Executive Appointments	17-12-12	CI
UroGen Pharma Ltd. Appoints Cynthia Butitta as Director	17-11-02	CI

No results for this search